Anya

How Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly

Jason Kelly, Sonya Huang, Pat Grady, Anya

Ginkgo Bioworks is executing a strategic pivot from traditional biological design to AI-driven autonomous laboratories, partnering with OpenAI to demonstrate that reasoning models can conduct high-volume experiments with 40% greater efficiency than current state-of-the-art benchmarks. Founder Jason Kelly argues that this shift addresses critical inefficiencies in global science by replacing costly human overhead with 24/7 robotic operations, a move he views as a national security imperative to compete with China's rapidly scaling biotech sector. By transitioning to a cloud-based, usage-pricing model and leveraging specialized robotics over humanoids, the company aims to democratize access to experimental science while fundamentally altering the economics of drug discovery and industrial biotechnology.